1. COUNTRY-DEPENDENT OUTCOME DIFFERENCES AFTER KIDNEY TRANSPLANTATION IN FRANCE VS. GERMANY – AN ADDITIONAL ANALYSIS OF THE ATHENA STUDY. Issue 3 (September 2020) Authors: Suwelack, Barbara; Thaiss, Friedrich; Sommerer, Claudia; Dragun, Duska; Hauser, Ingeborg A.; Witzke, Oliver; Hugo, Christian; Schenker, Peter; Merville, Pierre; Kamar, Nassim; Kroeger, Irena; Junge, Martina; Nashan, Björn Journal: Transplantation Issue: Volume 104:Issue 3(2020) Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. MANDELA Study Results at 18 Months after Heart Transplantation: Superior renal function with CNI-free everolimus over standard CNI-based regimen- a randomized, multi-center trial in de novo heart transplant recipients. (July 2018) Authors: Barten, Markus J; Hirt, Stephan W; Garbade, Jens; Bara, Christoph; Doesch, Andreas; Knosalla, Christoph; Grinninger, Carola; Stypmann, Joerg; Sieder, Christian; Junge, Martina; Schulz, Uwe Journal: Transplantation Issue: Volume 102(2018)Supplement 7S-1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Outcomes on Allograft Function after 12 Months with Everolimus Plus either Tacrolimus or Cyclosporine Compared to a Standard Tacrolimus-MPA Regimen in De Novo Renal Transplant Recipients: The Athena Study. (July 2018) Authors: Schenker, Peter; Sommerer, Claudia; Suwelack, Barbara; Dragun, Duska; Hauser, Ingeborg A; Witzke, Oliver; Hugo, Christian; Kamar, Nassim; Merville, Pierre; Junge, Martina; Thaiss, Friedrich; Nashan, Björn Journal: Transplantation Issue: Volume 102(2018)Supplement 7S-1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Significant Anti-CMV/BKV Effect of a Modern Everolimus-Based Regimen Comparted to Standard Tacrolimus-MPA Regimen in de Novo Kidney Transplant Recipients: Athena 12 months Data on Infections. (July 2018) Authors: Dragun, Duska; Suwelack, Barbara; Sommerer, Claudia; Hauser, Ingeborg A; Witzke, Oliver; Hugo, Christian; Kamar, Nassim; Merville, Pierre; Schenker, Peter; Junge, Martina; Thaiss, Friedrich; Nashan, Björn Journal: Transplantation Issue: Volume 102(2018)Supplement 7S-1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The Athena Study: 12 Months Safety and Efficacy Data for Everolimus Combined with Tacrolimus or Cyclosporine Compared to a Standard Tacrolimus-Mycophenolate Regimen in de Novo Kidney Transplant Patients. (July 2018) Authors: Nashan, Björn; Sommerer, Claudia; Suwelack, Barbara; Dragun, Duska; Hauser, Ingeborg A; Witzke, Oliver; Hugo, Christian; Kamar, Nassim; Merville, Pierre; Schenker, Peter; Junge, Martina; Thaiss, Friedrich Journal: Transplantation Issue: Volume 102(2018)Supplement 7S-1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗